Prevention of Cancer-by Agents that Suppress Oxygen Radical Formation

References

• Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries. with special reference to dietary factors. International Journal of Cancer. 1975; 15: 617–631
   PubMed Web of Science ®Google Scholar
• Carroll K. K. Experimental evidence of dietary factors and hormonedependent cancers. Cancer Research 1975; 35: 3374–3383
   PubMed Web of Science ®Google Scholar
• Phillips R. L. Role of life style and their habits in risk of cancer among Seventh-Day Adventists. Cancer Research. 1975; 35: 3513–3522
   PubMed Web of Science ®Google Scholar
• Berenblum I. The cocarinogenic action of croton resin. Cancer Research. 1941; 1: 44–48
   Google Scholar
• Hecker E. Cocarcinogenic principles from the seed oil of Crolon tiglium and from other euphorbiaceae. Cancer Research. 1968; 28: 2338–2349
   PubMed Web of Science ®Google Scholar
• Van Duuren B. L., Orris L. The tumor-enhancing principles of. Croton riglium. Cancer Research. 1965; 25: 1871–1875
   PubMed Web of Science ®Google Scholar
• Fujiki H., Mori M., Nakayasu M., Terda T., Sugimura T., Moore R. E. Indole alkaloids: Dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters. Proceedings of the National Academy of Sciences USA. 1981; 78: 3872–3876
   PubMed Web of Science ®Google Scholar
• Boutwell R. K. Some biological aspects of skin carcinogenesis. Progress in Experimental Tumor Research 1964; 4: 207–250
   PubMed Web of Science ®Google Scholar
• Boutwell R. K. Diet and anticarcinogenesis in the mouse skin two-stage model. Cancer Research 1983; 43(Suppl.)2465s–2468s
   Google Scholar
• Kinzel V., Fürstenberger G., Loehrke H., Marks F. Three-stage tumorigenesis in mouse skin: DNA synthesis as a prerequisite for the conversion stage induced by TPA prior to initiation. Carcinogenesis. 1986; 7(5)779–782
   PubMedGoogle Scholar
• Slaga T. J., Fischer S. M., Nelson K., Gleason G. L. Studies on mechanism of action of anti-tumor-promoting agents: Evidence for several stages in promotion. Proceedings of the National Acadcmy of Sciences USA 1980; 77: 3659–3663
   PubMed Web of Science ®Google Scholar
• Knight W. A., Livingstone R. B., Gregory E. J., McGuire W. L. Estrogen receptors as an independent prognostic factor for early recurrence in breast cancer. Cancer Research. 1977; 37: 4669–4671
   PubMed Web of Science ®Google Scholar
• Pollard M., Luckert P. H. Promotional effects of testosterone and dietary fat on the development of autochronous prostate cancer in rats. Cancer Letters. 1986; 32: 223–227
   PubMedGoogle Scholar
• Weinstein I. B. Multistage carcinogenesis: A progressive disorder in signal transduction. Proceedings of the American Association for Cancer Research. 1989; 30: 683
   Google Scholar
• Nakayasu M., Shima H., Aonuma S., Nakagama H., Nagao M., Sugimura T. Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADP-ribox)polymcrase. Proceedings of the National Academy of Sciences USA 1988; 85: 9066–9070
   PubMedGoogle Scholar
• Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Noture. 1984; 308: 693
   PubMed Web of Science ®Google Scholar
• Troll W., Wiesner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Annual Review of Pharmacology and Toxicology. 1985; 25: 509–528
   PubMed Web of Science ®Google Scholar
• Troll W., Frenkel K., Wianer R. Protease inhibitors as anticarcinogens. Journal of the National Cancer Institute. 1984; 73(6)1245–1250
   PubMedGoogle Scholar
• Troll W. Cancer prevention by inhibitors of tumor promotion. Proceedings of the American Association for Cancer Research. 1989; 30: 684–685
   Google Scholar
• Hozumi M., Ogawa M., Sugimura T., Takeuchi T., Umezawr H. Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from. Actinomycetes. Cancer Research. 1972; 32: 1725–1729
   PubMed Web of Science ®Google Scholar
• Correa P. Epidemiological correlations between diet and cancer frequency. Concer Research. 1981; 41: 3685–3690
   PubMed Web of Science ®Google Scholar
• Verma A. K., Shapas B. G., Rice H. M., Boutwell R. K. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Research. 1979; 39: 419–425
   PubMed Web of Science ®Google Scholar
• Hennings H., Blumberg P. M., Pettit G. R., Herrald C. L., Shores R., Yuspa C. H. Bryostatin I an activator of protein kinase C inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis (Lond.) 1981; 8: 1343–1346
   Google Scholar
• Kraft A. S., William F., Pettit G. R., Lilly M. B. Varied differentiation responses of human leukemias to bryostatin I. Cancer Research. 1989; 49: 1287–1293
   PubMed Web of Science ®Google Scholar
• Fujiki H., Suganuma M., Suguri H., Yoshizawa S., Takagi K., Kobayashi M. Sarcophytols A and B inhibit tumor promotion by teleocidin in two-stage carcinogenesis in mouse skin. Journal of Cancer Research in Clinical Oncology 1989; 115: 25–28
   PubMedGoogle Scholar
• Narisawa T., Takahashi M., Niwa M., Fukaura Y., Fujiki H. Inhibition of methylnitrosourea-induced large bowel cancer development in rats by Sarcophytol A, a product from a marine soft coral. Surcophyton glaucum. Cancer Research. 1989; 49: 3287–3289
   PubMed Web of Science ®Google Scholar
• Slaga T. J., Klein-Szanto A. J. P., Triplett L. L., Yotti L. P., Trosko J. E. Skin tumor promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 1981; 213: 1023–1025
   PubMed Web of Science ®Google Scholar
• Badwey J. A., Karnovsky M. L. Active oxygen species and the functions of phagocytic leukocytes. Annual Review of Biochemistry. 1980; 49: 695–726
   PubMed Web of Science ®Google Scholar
• Fantone J. C., Ward P. A. Role of oxygen-derived free radicals and metabolites in leukocytedependent inflammatory reactions. American Journal of Pathology. 1982; 107: 397–418
   Web of Science ®Google Scholar
• Formisano J., Troll W., Sugimura T. Superoxide response induced by indole alkaloid tumor promoters. Annals of the New York Academy of Science 1983; 407: 429–431
   Google Scholar
• Janoff A., Kiasxn A., Troll W. Local vascular changes induced by the cocarcinogen, phorbol myristate acetate. Cancer Research. 1970; 30: 2568–2571
   PubMed Web of Science ®Google Scholar
• Klebanoff S. J. Oxygen metabolism and the toxic properties of phagocytes. Annals of Internal Medicine 1980; 93: 480–489
   PubMed Web of Science ®Google Scholar
• Frenkel K., Chrzan K. Hydrogen peroxide formation and DNA base modification by tumor promoter-activated polymorphonuclear leukocytes. Carcinogenesis 1987; 8(3)455–460
   PubMedGoogle Scholar
• Goldstein B. W., Witz G., Amoruso M., Stone D. S., Troll W. Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters. Cancer Letters. 1981; 11: 257–262
   PubMed Web of Science ®Google Scholar
• Frenkel K., Chrzan K., Ryan C., Wiesner R., Troll W. Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes. Carcinogenesis. 1957; 8: 1207–1212
   Google Scholar
• Troll W., Frenkel K., Teebor G. Free oxygen radicals: Necessary contributors to tumor promotion and cocarinogenesis. Cellular Interactions by Environmental Tumor Promoters, H. Fujiki, E. Hecker, R. E. Moore, T. Sugimura, I. B. Weinstein. Japan Scientific Societies Press. Tokyo/VNU Science Press BV, Utrecht 1984; 207–218
   Google Scholar
• Troll W., Wiesner R., Frenkel K. Anticarcinogenic action of protease inhibitors. Advances in Cancer Res., G. Klein, S. Weinhouse. Academic Press, Inc., New York 1987; vol. 49: 265–283
   Google Scholar
• Cleaver J. E., Banda M. J., Troll W., Borek C. Some protease inhibitors are also inhibitors of poly(ADP-ribose) polymerase. Carcinogenesis. 1986; 7(2)323–325
   PubMedGoogle Scholar
• Garte S. J., Currie D., Motz J., Troll W. Inhibition of H-ras oncogene transformation of NIH 3T3 cells by protease inhibitors. Cancer Research. 1988; 47: 3159–3162
   Google Scholar
• Diamond A. M., Der C. J., Schwartz J. L. Alterations in transformation efficiency by the ADPRT-inhibitor 3-aminobenzamide are oncogene specific. Carcinogenesis. 1989; 10(2)383–385
   PubMedGoogle Scholar
• Garte S. J., Currie D. D., Troll W. Retinoic acid inhibits transformation of NIH 3T3 cells by the human H-ras oncogene. Proceedings of the Amcrican Association of Cancer Research. 1987; 29: 140
   Google Scholar
• Bürkle A., Meyer T., Hilz H., zur Hausen H. Enhancement of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA amplification in a simian virus 40-transformed Chinese hamster cell line by 3-aminobenzamide. Cancer Research. 1987; 47: 3632–3636
   PubMedGoogle Scholar
• Heilbronn R., Schleohofer J. R., Yalkinoglu A. O., zur Hausen H. Selective DNA amplification induced by carcinogens (initiators): Evidence for a role of proteases and DNA polymerase α. International Journal of Cancer. 1985; 36: 85–91
   PubMed Web of Science ®Google Scholar
• Borek C., Troll W. Modifiers of free radicals inhibit in vitro the oncogcnic actions of X-rays, bleomycin, and the tumor promoter 12-O-tetradccanoylphorobl 13-acetate. Proceedings of the National Academy of Sciences USA 1983; 80: 1304–1307
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Chemoprevention of cancer. Cancer Research 1985; 45: 18
   Google Scholar